Starting a company is challenging, especially for women facing sexism in male-dominated environments, which can hinder their ability to attract investment. Learn strategies for female founders to succeed in the science business:
Springer Nature
@SpringerNature
Leading research publisher empowering researchers, educators, and health professionals with our trusted brands for 180+ years. Site notice: bit.ly/2oAyLi1
- A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the companies behind the trial announced this week. The vaccine is the first mRNA-based cancer treatment to show success in a late-stage trial:
- One of our top-rated articles on @altmetric this past week was published open access in @NatureHumBehav. You can read 'Voluntary attention regulates acute immune responses in humans' here:
- Globally, snakebites kill 80K - 140K people a year and lead to around 400K disabilities. Because many who are bitten live in rural areas, access to antivenom is insufficient. Researchers found that rattlesnakes’ own antivenom could protect humans too:
- Springer Nature, the African Academy of Sciences (@AASciences) and the Academy of Science of South Africa (@ASSAf_Official) have launched the first continent-wide survey examining researchers’ experiences of research integrity training and support. spklr.io/6019ERaix
